Prasugrel Hydroxy Thiolactone
| Product Name | Prasugrel Hydroxy Thiolactone |
|---|---|
| Alternate Names | Prasugrel Impurities, Impurities of Prasugrel |
| CAT No. | CS-T-60709 |
| CAS No. | 947502-66-1 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 347.40 g/mol |
| Mol. For. | C₁₈H₁₈FNO₃S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Prasugrel |
| Therapeutic | Anti-Thrombotics |
| Canonical Smiles | C1CC1C(=O)C(C2=CC=CC=C2F)N3CCC4(C(=CC(=O)S4)C3)O |
| InchIKey | OHANBBNBMKFHBI-UHFFFAOYSA-N |
| Inchl | InChI=1S/C18H18FNO3S/c19-14-4-2-1-3-13(14)16(17(22)11-5-6-11)20-8-7-18(23)12(10-20)9-15(21)24-18/h1-4,9,11,16,23H,5-8,10H2 |
| IUPAC | 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-7a-hydroxy-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-one |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Prasugrel Hydroxy Thiolactone is a chemical compound that belongs to the thienopyridine class of antiplatelet agents. It is used as an antiplatelet medication to prevent blood clots formation in patients with acute coronary syndrome, including those undergoing percutaneous coronary intervention (PCI). Prasugrel Hydroxy Thiolactone works by inhibiting the platelet activation and aggregation process, which is a critical step in the formation of blood clots.
Chemically, Prasugrel Hydroxy Thiolactone is a prodrug, which means it is inactive until it is metabolized in the liver to its active form, Prasugrel. This conversion process involves hydrolysis of the thiolactone ring, which releases the active metabolite. The active metabolite of Prasugrel Hydroxy Thiolactone irreversibly binds to the P2Y12 receptor on the platelet surface, which inhibits ADP-induced platelet aggregation and reduces the risk of thrombotic events.
Prasugrel Hydroxy Thiolactone is available in the form of oral tablets, and the recommended dosage depends on the patient's weight and medical condition. It is contraindicated in patients with a history of bleeding, stroke, or transient ischemic attack (TIA). Prasugrel Hydroxy Thiolactone may also interact with other medications, such as anticoagulants and nonsteroidal anti-inflammatory drugs (NSAIDs), which can increase the risk of bleeding.
In conclusion, Prasugrel Hydroxy Thiolactone is a potent antiplatelet medication that effectively prevents blood clot formation in patients with acute coronary syndrome. Its chemical structure and mechanism of action are critical in understanding its pharmacological properties and potential interactions with other medications.
Get an Instant Quote
Related Compounds
Descyclopropyl-2-oxopropyl Prasugrel | Prasugrel Endo iminium impurity | Prasugrel Impurity 29 | Di-Acetyl Prasugrel HCl Impurity | Prasugrel Impurity F | p-Fluoro Prasugrel Hydrochloride | Prasugrel cyclopropyl open ring impurity-1 | PRASUGREL 3-FLUORO IMPURITY | PRASUGREL 4-FLUORO IMPURITY | Prasugrel Impurity 27 | Bromo Prasugrel | Prasugrel EP Impurity F trifluoroacetate alt | Prasugrel Impurity 26 | Desacetyl hydroxy prasugrel impurity | m-Fluoro Prasugrel Hydrochloride | Prasugrel cyclopropyl open ring impurity-2 | Prasugrel Impurity 25 | Prasugrel Impurity 19 | Prasugrel Impurity of KSM-ll | Prasugrel Bromo Opened Ring Impurity | Defluoro Prasugrel Hydrochloride | Prasugrel Impurity 4 | Prasugrel Impurity 39 | Prasugrel Carboxyenone impurity |